Saturday, 31 October 2026European Markets

HOTELS DE PARIS Stock Went Up By Over 33% In The Last 21 Sessions

Loading stream...

hotels de paris, denoted as cac 40: hdp.pa in the stock market, currently showcases unexpected behavior in terms of its share price. an unusual growth of 33.33% within the span of 21 sessions has been witnessed, leapfrogging from eur1.95 to eur2.60. this statistic stands in contrast with the performance of paris' cac 40 index, which exhibits a reduction of 1.08%.

company profile and earnings per share

les hotels de paris sa, set up in 1992, boasts a widespread collection of 17 hotels located across paris, st tropez, and marrakech, in addition to other properties. despite its impressive portfolio, the company's trailing twelve month earnings per share (eps) is recorded at eur-0.64, implying a struggle with generating profit.

stock identification and volatility

as per the stochastic oscillator, an indicator used for tracking momentum, the stock of hotels de paris is denoted as oversold. this may hint at beneficial purchasing opportunities for investors who keep this metric into consideration.

volatility is indeed a significant element that potential investors should comprehend. as observed last week, the stock had an average intraday fluctuation of 0.79%; over the last month, it endured a volatility of 1.99%; and the highest volatility of 7.07% was recorded last month.

trading volume and financial health evaluation

contrary to the standard, today's reported volume for hotels de paris was considerably lower than usual. the current number at 207 starkly compares to the average trading activity of 1097. this indicates a sudden decrease in trading activity, which may essentially diminish the liquidity of this stock. moreover, it could influence a potential investor's decision, specifically while considering buying or selling this security.

despite the encouraging growth in stock price demonstrated in recent months, investors are advised to exercise caution. comprehensive evaluation of the company's monetary health alongside the current market volatility and trading activity is recommended before finalizing any investment decision.

more news about hotels de paris (hdp.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com